INNOVATION PHARMACEUTICALS INC. (IPIX)
Clinical trial NCT04962061 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-12-31 → 2026-03-03 3. primary completion date: 2025-12-31 → 2026-02-06 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT04962061 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2025-12-31 → 2026-03-03 3. primary completion date: 2025-12-31 → 2026-02-06 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (63%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical